- Conditions
- Critical Illness
- Interventions
- Indirect - other patients, Indirect - physiology, Redirection, Direct communication
- Behavioral
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 302 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–17
of 17
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Hemiplegic Cerebral Palsy
- Interventions
- Dual Joint Visual Feedback without Scoring, Dual Joint Visual Feedback with Scoring
- Device
- Lead sponsor
- Kessler Foundation
- Other
- Eligibility
- 7 Years to 17 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- West Orange, New Jersey
- Conditions
- Relapsed/ Refractory Multiple Myeloma
- Interventions
- Talquetamab, Teclistamab, PD-1 Inhibitor
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 74 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 7
- States / cities
- Denver, Colorado • New York, New York • Winston-Salem, North Carolina + 1 more
- Conditions
- Profound Autism
- Interventions
- CAST Treatment
- Behavioral
- Lead sponsor
- University of Nebraska
- Other
- Eligibility
- 10 Years to 17 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Omaha, Nebraska
- Conditions
- Inappropriate Prescribing
- Interventions
- Z-drug Default Quantity, Redirection + Accountable Justification
- Behavioral
- Lead sponsor
- University of Southern California
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 444 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Emotional Regulation, Alcohol Drinking in College, Emotional Eating, Aggression
- Interventions
- Momentary coping prompt, Active control message
- Behavioral
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years to 22 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Diffuse Large B-Cell Lymphoma
- Interventions
- Bridging Radiation Therapy
- Other
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Carotid Stenosis, Carotid Artery Diseases
- Interventions
- Neuroguard IEP Direct System
- Device
- Lead sponsor
- Contego Medical, Inc.
- Industry
- Eligibility
- 20 Years to 82 Years
- Enrollment
- 178 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 30
- States / cities
- Scottsdale, Arizona • Hartford, Connecticut • Washington D.C., District of Columbia + 25 more
- Conditions
- Hematological Malignancies
- Interventions
- Talquetamab
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 510 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2029
- U.S. locations
- 14
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Duarte, California + 10 more
- Conditions
- Socioemotional Development
- Interventions
- Individual play sessions, Peer play sessions, Classroom push-in sessions
- Behavioral
- Lead sponsor
- The Children's Institute
- Other
- Eligibility
- 3 Years to 6 Years
- Enrollment
- 225 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Multiple Myeloma
- Interventions
- Daratumumab, Talquetamab, Teclistamab, Pomalidomide
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 290 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2027
- U.S. locations
- 10
- States / cities
- Duarte, California • Irvine, California • San Francisco, California + 6 more
- Conditions
- Emotional Regulation, Alcohol Drinking in College, Emotional Eating, Aggression
- Interventions
- Momentary coping prompt, Active control message
- Behavioral
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years to 22 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Attention Disturbances
- Interventions
- mind-wandering intervention, mind-wandering comparison
- Behavioral
- Lead sponsor
- University of Houston
- Other
- Eligibility
- 11 Years to 15 Years
- Enrollment
- 53 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Cerebral Palsy
- Interventions
- Dynamic Supported Mobility, Conventional Therapy
- Other
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 12 Months to 36 Months
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2020
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Multiple Myeloma
- Interventions
- Talquetamab, Teclistamab
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 228 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2026
- U.S. locations
- 13
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Denver, Colorado + 9 more
- Conditions
- Normal Voice
- Interventions
- Complete airflow interruption, Incomplete airflow interruption, Airflow redirection
- Device
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 4 Years to 65 Years
- Enrollment
- 365 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2030
- U.S. locations
- 2
- States / cities
- Iowa City, Iowa • Madison, Wisconsin
- Conditions
- Jaundice, Jaundice, Neonatal
- Interventions
- Ring Phototherapy
- Device
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- Up to 7 Days
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota